Similarly, MCP-1 was demonstrated to be elevated prior to the onset of RA in humans [82], and an antagonist of MCP-1 was shown to prevent the onset of RA on a mouse model [83]. This evidence concerns the gene CCL2 and rheumatoid arthritis.